CCMH
BIVV

Cornerstone Capital Management Holdings’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-12,068
Closed -$687K – 1384
2017
Q3 		$687K Buy
12,068
+168
+1% +$9.84K 0.01% 1001
2017
Q2 		$716K Buy
+11,900
New +$678K 0.01% 978

Other funds holding BIVV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

Cornerstone Capital Management Holdings's BIVV Position: Q4 2017 in Review

Cornerstone Capital Management Holdings sold out of Bioverativ Inc. Common Stock (BIVV) in Q4 2017, closing a stake of 12,068 shares — an estimated $687K sold.

Cornerstone Capital Management Holdings first reported a position in BIVV in Q2 2017 and held it in 2 quarters. The position peaked at $716K in Q2 2017. 459 funds tracked by Wall St. Rank hold BIVV as of Q4 2017.

  • Cornerstone Capital Management Holdings reported no remaining Bioverativ Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 12,068 Bioverativ Inc. Common Stock shares in Q4 2017, an estimated $687K.
  • Cornerstone Capital Management Holdings first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 2 quarters.
  • Cornerstone Capital Management Holdings's Bioverativ Inc. Common Stock position peaked at $716K in Q2 2017.
  • 459 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.